Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and sacubitril

glucose, (beta-d)-isomer has been researched along with sacubitril in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Aboalhasan, E; Arbel, R; Azuri, J; Hammerman, A2
Karabulut, D; Karabulut, U; Keskin, K; Yiğit, E; Yiğit, Z1
Anker, SD; Butler, J; Ferreira, JP; Filipattos, G; Kraus, BJ; Packer, M; Pocock, SJ; Ritter, I; Schüler, E; Zannad, F1
Bachir, N; Boukabous, A; Terki, A; Zaoui, N1

Other Studies

5 other study(ies) available for glucose, (beta-d)-isomer and sacubitril

ArticleYear
Dapagliflozin vs. sacubitril-valsartan for prevention of heart failure events in non-diabetic patients with reduced ejection fraction: a cost per outcome analysis.
    European journal of preventive cardiology, 2021, 12-29, Volume: 28, Issue:15

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Biphenyl Compounds; Drug Combinations; Glucosides; Heart Failure; Humans; Stroke Volume; Treatment Outcome; Valsartan

2021
Effect of Sacubitril/Valsartan Combined with Dapagliflozin on Long-Term Cardiac Mortality in Heart Failure with Reduced Ejection Fraction.
    Angiology, 2022, Volume: 73, Issue:4

    Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Biphenyl Compounds; Drug Combinations; Glucosides; Heart Failure; Humans; Male; Retrospective Studies; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Ventricular Function, Left

2022
Dapagliflozin Versus Sacubitril-Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:3

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Biphenyl Compounds; Diabetes Mellitus, Type 2; Drug Combinations; Glucosides; Heart Failure; Humans; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Tetrazoles; Valsartan; Ventricular Dysfunction, Left

2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
    European heart journal, 2022, 08-14, Volume: 43, Issue:31

    Topics: Aminobutyrates; Benzhydryl Compounds; Biphenyl Compounds; Glucosides; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Potassium; Stroke Volume; Ventricular Function, Left

2022
[Impact of Dapagliflozin on echocardiographic parameters in patients with heart failure and reduced ejection fraction: "About a monocentric series of 43 cases"].
    Annales de cardiologie et d'angeiologie, 2022, Volume: 71, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aminobutyrates; Benzhydryl Compounds; Biphenyl Compounds; Echocardiography; Glucosides; Heart Failure; Humans; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Stroke Volume

2022